Atom | Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)

Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $200,000 direct costs per year, not to exceed $275,000 total over 2 years (R21 mechanism)

Summary: Supports exploratory research to develop advanced human cell-derived microphysiological systems (MPS) that replicate complex nervous system architectures and physiology.

Key Information: Clinical trials are not allowed; high-risk/high-reward, early-stage projects are encouraged; foreign organizations are eligible.

Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)

Sign in to see full grant listing